Gradishar WJ - Search Results

1

Adjuvant chemotherapy in patients with invasive lobular carcinoma and use of the 21-gene recurrence score: A National Cancer Database analysis.

Weiser R, Polychronopoulou E, Hatch SS, Haque W, Ghani HA, He J, Kuo YF, Gradishar WJ, Klimberg VS. Weiser R, et al. Among authors: gradishar wj. Cancer. 2022 May 1;128(9):1738-1747. doi: 10.1002/cncr.34127. Epub 2022 Feb 9. Cancer. 2022. PMID: 35137951 Free article.

2

The impact on survival by adjuvant chemotherapy and radiation therapy in stage II non-small-cell lung cancer.

Gradishar WJ, Mick R, Hoffman PC, Bitran JD, Krishnasamy S, Ferguson MK, Golomb HM. Gradishar WJ, et al. Am J Clin Oncol. 1992 Oct;15(5):405-11. doi: 10.1097/00000421-199210000-00004. Am J Clin Oncol. 1992. PMID: 1326225

3

Chemotherapy-related hemolytic-uremic syndrome after the treatment of head and neck cancer. A case report.

Gradishar WJ, Vokes EE, Ni K, Panje WR. Gradishar WJ, et al. Cancer. 1990 Nov 1;66(9):1914-8. doi: 10.1002/1097-0142(19901101)66:9<1914::aid-cncr2820660910>3.0.co;2-g. Cancer. 1990. PMID: 2224786

4

High-dose chemotherapy for breast cancer.

Gradishar WJ, Tallman MS, Abrams JS. Gradishar WJ, et al. Ann Intern Med. 1996 Oct 1;125(7):599-604. doi: 10.7326/0003-4819-125-7-199610010-00010. Ann Intern Med. 1996. PMID: 8815759 Review.

5

High-dose chemotherapy and autologous stem cell transplantation as treatment for high-risk breast cancer.

Tallman MS, Gradishar WJ. Tallman MS, et al. Among authors: gradishar wj. Cancer Chemother Pharmacol. 1998;42 Suppl:S60-7. doi: 10.1007/s002800051081. Cancer Chemother Pharmacol. 1998. PMID: 9750031 Review.

6

Phase II study of all-trans-retinoic acid and alpha-interferon in patients with advanced non-small cell lung cancer.

Athanasiadis I, Kies MS, Miller M, Ganzenko N, Joob A, Marymont M, Rademaker A, Gradishar WJ. Athanasiadis I, et al. Among authors: gradishar wj. Clin Cancer Res. 1995 Sep;1(9):973-9. Clin Cancer Res. 1995. PMID: 9816069 Clinical Trial.

7

Effects of high dose raloxifene in selected patients with advanced breast carcinoma.

Gradishar W, Glusman J, Lu Y, Vogel C, Cohen FJ, Sledge GW Jr. Gradishar W, et al. Cancer. 2000 May 1;88(9):2047-53. doi: 10.1002/(sici)1097-0142(20000501)88:9<2047::aid-cncr10>3.0.co;2-e. Cancer. 2000. PMID: 10813716

8

The evolving role of endocrine therapy for treatment and prevention of breast cancer.

Gradishar WJ, Jordan VC. Gradishar WJ, et al. Cancer Chemother Biol Response Modif. 2001;19:215-36. Cancer Chemother Biol Response Modif. 2001. PMID: 11686016 Review. No abstract available.

9

A Phase II trial of cisplatin plus WR-2721 (amifostine) for metastatic breast carcinoma: an Eastern Cooperative Oncology Group Study (E8188).

Gradishar WJ, Stephenson P, Glover DJ, Neuberg DS, Moore MR, Windschitl HE, Piel I, Abeloff MD. Gradishar WJ, et al. Cancer. 2001 Nov 15;92(10):2517-22. doi: 10.1002/1097-0142(20011115)92:10<2517::aid-cncr1602>3.0.co;2-z. Cancer. 2001. PMID: 11745184 Clinical Trial.

10

A rationale for the reinitiation of adjuvant tamoxifen therapy in women receiving fewer than 5 years of therapy.

Gradishar WJ, Hellmund R. Gradishar WJ, et al. Clin Breast Cancer. 2002 Jan;2(4):282-6. doi: 10.3816/cbc.2002.n.003. Clin Breast Cancer. 2002. PMID: 11899359 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

318 results

Search Page

Filters